Cargando…

Antifungal Activity of ZnO Nanoparticles and Nystatin and Downregulation of SAP1-3 Genes Expression in Fluconazole-Resistant Candida albicans Isolates from Vulvovaginal Candidiasis

PURPOSE: Antifungal resistance and virulence properties of Candida albicans (C. albicans) are growing health problems worldwide. The present study aims to investigate the effect of Zinc Oxide (ZnO) nanoparticles and Nystatin on SAP1-3 genes expression in C. albicans isolates of females with Vulvovag...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosseini, Seyededeh Sedigheh, Joshaghani, Hamidreza, Shokohi, Tahereh, Ahmadi, Alireza, Mehrbakhsh, Zahra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7025901/ https://www.ncbi.nlm.nih.gov/pubmed/32104010 http://dx.doi.org/10.2147/IDR.S226154

Ejemplares similares

Ultrasound-Assisted Preparation of Exopolysaccharide/Nystatin Nanoemulsion for Treatment of Vulvovaginal Candidiasis
por: Song, Ruiteng, et al.
Publicado: (2020)

Antimicrobial Photodynamic Therapy in Combination with Nystatin in the Treatment of Experimental Oral Candidiasis Induced by Candida albicans Resistant to Fluconazole
por: Janeth Rimachi Hidalgo, Karem, et al.
Publicado: (2019)

Nystatin enhances the immune response against Candida albicans and protects the ultrastructure of the vaginal epithelium in a rat model of vulvovaginal candidiasis
por: Zhang, Xu, et al.
Publicado: (2018)

Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis
por: Nouraei, S., et al.
Publicado: (2012)

Antifungal effect of Atorvastatin against Candida species in comparison to Fluconazole and Nystatin
por: Esfahani, Ava Nasr, et al.
Publicado: (2019)

Corrigendum to “Comparison between Fluconazole with Oral Protexin Combination and Fluconazole in the Treatment of Vulvovaginal Candidiasis”
por: Nouraei, S., et al.
Publicado: (2017)

Molecular Identification and Antifungal Susceptibility Pattern of Non-albicans Candida Species Isolated from Vulvovaginal Candidiasis
por: Nejat, Ziba Abbasi, et al.
Publicado: (2018)

Overexpression of MDR-1 and CDR-2 genes in fluconazole resistance of Candida albicans isolated from patients with vulvovaginal candidiasis
por: Khosravi Rad, K, et al.
Publicado: (2016)

Low prevalence of antifungal resistant Candida africana, in the C. albicans complex causing vulvovaginal candidiasis
por: Farahyar, Shirin, et al.
Publicado: (2020)

Oral Nystatin Versus Intravenous Fluconazole as Neonatal Antifungal Prophylaxis: Non-inferiority Trial
por: Mersal, Ali, et al.
Publicado: (2013)

Phase 2 Randomized Study of Oral Ibrexafungerp Versus Fluconazole in Vulvovaginal Candidiasis
por: Nyirjesy, Paul, et al.
Publicado: (2021)

The Effects of Cinnamaldehyde (Cinnamon Derivatives) and Nystatin on Candida Albicans and Candida Glabrata
por: Bakhtiari, Sedigheh, et al.
Publicado: (2019)

Investigation of the antifungal effects of curcumin against nystatin-resistant Candida albicans
por: Hajifathali, Soha, et al.
Publicado: (2023)

Preparation, characterization and properties of three different nanomaterials either alone or loaded with nystatin or fluconazole antifungals
por: Helal, Sara H., et al.
Publicado: (2022)

Antifungal Susceptibility of Oral Candida Isolates from Mother-Infant Dyads to Nystatin, Fluconazole, and Caspofungin
por: Alkhars, Naemah, et al.
Publicado: (2023)

Kangbainian Lotion Ameliorates Vulvovaginal Candidiasis in Mice by Inhibiting the Growth of Fluconazole-Resistant Candida albicans and the Dectin-1 Signaling Pathway Activation
por: Chen, Zewei, et al.
Publicado: (2022)

Antifungal activity of linalool against fluconazole-resistant clinical strains of vulvovaginal Candida albicans and its predictive mechanism of action
por: Medeiros, C.I.S., et al.
Publicado: (2022)

Vulvovaginal candidiasis: species distribution of Candida and their antifungal susceptibility pattern
por: Bitew, Adane, et al.
Publicado: (2018)

Species distribution and susceptibility profiles of Candida species isolated from vulvovaginal candidiasis, emergence of C. lusitaniae
por: Hashemi, Seyed Ebrahim, et al.
Publicado: (2019)

Molecular association of Candida albicans and vulvovaginal candidiasis: focusing on a solution
por: David, Helma, et al.
Publicado: (2023)

The comparison of the effect of curcumin with nystatin on inhibition level of Candida albicans
por: Nosratzehi, Tahereh, et al.
Publicado: (2019)

A Comparison of the eFficacy of Nystatin and Fluconazole Incorporated into Tissue Conditioner on the In Vitro Attachment and Colonization of Candida Albicans
por: Falah-Tafti, Abbas, et al.
Publicado: (2010)

Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis
por: Ge, Gai, et al.
Publicado: (2022)

Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
por: Shi, Yu, et al.
Publicado: (2020)

Coadministration of Ginger Extract and Fluconazole Shows a Synergistic Effect in the Treatment of Drug-Resistant Vulvovaginal Candidiasis
por: Khan, Arif, et al.
Publicado: (2021)

Antifungal Properties of Biogenic Selenium Nanoparticles Functionalized with Nystatin for the Inhibition of Candida albicans Biofilm Formation
por: Nile, Shivraj Hariram, et al.
Publicado: (2023)

Correction to: Molecular identification and antifungal susceptibility profile of yeast from vulvovaginal candidiasis
por: Shi, Yu, et al.
Publicado: (2022)

Comparing the Effect of Probiotic and Fluconazole on Treatment and Recurrence of Vulvovaginal Candidiasis: a Triple-Blinded Randomized Controlled Trial
por: Mollazadeh-Narestan, Zahra, et al.
Publicado: (2022)

Glycogen Metabolism in Candida albicans Impacts Fitness and Virulence during Vulvovaginal and Invasive Candidiasis
por: Miao, Jian, et al.
Publicado: (2023)

Candidiasis vulvovaginal: revisión bibliográfica.
por: Caballero Salmeron, María Esther
Publicado: (1995)

New Treatments for Vulvovaginal Candidiasis
por: Faro, Sebastian
Publicado: (1996)

Changing Trends of Vulvovaginal Candidiasis
por: Vijaya, Doddaiah, et al.
Publicado: (2014)

Clinicomycological study of vulvovaginal candidiasis
por: Seeniammal, S., et al.
Publicado: (2021)

Antifungal Activity of Brazilian Propolis Microparticles against Yeasts Isolated from Vulvovaginal Candidiasis
por: Dota, Kelen Fátima Dalben, et al.
Publicado: (2011)

Efficacy of antifungal drugs in the treatment of vulvovaginal candidiasis: a Bayesian network meta-analysis
por: Qin, Fen, et al.
Publicado: (2018)

Antifungal (oral and vaginal) therapy for recurrent vulvovaginal candidiasis: a systematic review protocol
por: Lírio, Juliana, et al.
Publicado: (2019)

Antifungal Effect of Long Noncoding RNA 9708-1 in the Vulvovaginal Candidiasis Murine Model
por: Wu, Ying, et al.
Publicado: (2021)

Comparison of the antifungal effect of voriconazole and fluconazole on oral candidiasis before and during radiotherapy
por: Golestannejad, Zahra, et al.
Publicado: (2022)

Vaginal and oral use of probiotics as adjunctive therapy to fluconazole in patients with vulvovaginal candidiasis: A clinical trial on Iranian women
por: Vahedpoor, Zahra, et al.
Publicado: (2021)

In Vitro pH Activity of Ibrexafungerp against Fluconazole-Susceptible and -Resistant Candida Isolates from Women with Vulvovaginal Candidiasis
por: Sobel, Jack D., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_81jadua1tia4hvvmfveveu8c3b